Nuclear factor kappa B (
NF-kappa B) is a
transcription factor that is known to regulate apoptosis when cells are exposed to
DNA-damaging agents such as ionizing radiation and cytotoxic drugs. We sought to determine if inhibition of
NF-kappa B could enhance radiosensitivity in human
colon cancer cells in vitro and in vivo. To inhibit
NF-kappa B activation specifically, we constructed a recombinant adenovirus vector expressing a truncated form of the inhibitor
protein I kappa B alpha (
I kappa B alpha Delta N) that lacks the phosphorylation sites essential for activation of
NF-kappa B, and transfected two human
colon cancer cell lines (HT29 and HCT15) with this vector. In vitro colony-forming assays revealed that the overexpression of the stable
I kappa B alpha by AxI kappa B alpha Delta N
infection significantly suppressed cell growth after irradiation in both cell lines as compared to
infection with a control vector, AxLacZ. Treatment with AxI kappa B alpha Delta N and irradiation successfully inhibited the growth of HT29 xenografted subcutaneous
tumors in nude mice with an 83.8% volume reduction on day 38 as compared to the untreated
tumors. Furthermore, it was demonstrated that apoptosis was increased by adenovirus-mediated gene transduction of
I kappa B alpha Delta N in vitro and in vivo. These results indicated that inhibition of
NF-kappa B could enhance radiosensitivity through an increase in radiation-induced apoptosis. We believe that radio-gene therapy using adenovirus-mediated gene transduction of
I kappa B alpha Delta N could be an attractive candidate as a treatment strategy for
colorectal cancer.